PhaseBio Pharmaceuticals
PhaseBio Pharmaceuticals is a specialty biopharmaceutical company developing a range of biopolymers for endocrine and metabolic disorders and cardiovascular disease. The company is located in Malvern, PA. As of March 2016, the company has raised $144 million in the funding rounds with the most recent Series C round of $40 million.
The company was founded by Clay B. Thorp in 2002 and Jonathan Mow serves as CEO of the company.
Operations
The company's technology, elastin-like polypeptides, was initially developed by the team. The company is in the process of developing a treatment hyperglycemia, pulmonary arterial hypertension and Insumera.
The company was founded by Clay B. Thorp in 2002 and Jonathan Mow serves as CEO of the company.
Operations
The company's technology, elastin-like polypeptides, was initially developed by the team. The company is in the process of developing a treatment hyperglycemia, pulmonary arterial hypertension and Insumera.
Comments